91制片厂在线看

Eric S. Sandler, MD

Chair, Pediatrics, NCSCJ, FL

91制片厂在线看 Children's Health, Jacksonville 807 Children's Way Jacksonville, FL 32207

Fellowship

  • Pediatric Hematology/Oncology - University of Florida College of Medicine, 1991

Internship Residency

  • Pediatrics - University of California, SF, Medical School, 1988

Medical/Dental School

  • MD - University of Vermont, College of Medicine, 1985

Board Certifications

  • American Board of Pediatrics/Hematology-Oncology

  • Irradiating residual disease to 30 Gy with proton therapy in pediatric mediastinal Hodgkin lymphoma; International Journal of Particle Therapy; (2021).

  • Local Control After Proton Therapy for Pediatric Chordoma; International Journal of Radiation Oncology Biology Physics; (2021).

  • Long-term outcomes of pediatric and young adult patients receiving radiotherapy for nonmalignant vascular anomalies; Pediatric Blood and Cancer; (2021).

  • Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma; Pediatric Blood and Cancer; (2021).

  • Second tumor risk in children treated with proton therapy; Pediatric Blood and Cancer; (2021).

  • Implementation of family psychosocial risk assessment in pediatric cancer with the Psychosocial Assessment Tool (PAT): study protocol for a cluster-randomized comparative effectiveness trial; Implementation Science; (2020).

  • Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma; Practical Radiation Oncology; (2020).

  • Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base; Pediatric Blood and Cancer; (2020).

  • Patterns of Failure in Parameningeal Alveolar Rhabdomyosarcoma; International Journal of Radiation Oncology Biology Physics; (2020).

  • Surveillance imaging in pediatric ependymoma; Pediatric Blood and Cancer; (2020).

  • Enteral Nutrition in Pediatric High-risk Head and Neck Cancer Patients Receiving Proton Therapy: Identifying Risk Factors and Quality of Life Concerns to Optimize Care; Journal of Pediatric Hematology/Oncology; (2019).

  • Implementing screening with the Psychosocial Assessment Tool (PAT) in clinical oncology practice; Clinical Practice in Pediatric Psychology; (2019).

  • Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma; International Journal of Radiation Oncology Biology Physics; (2019).

  • Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma; Pediatric Blood and Cancer; (2019).

  • Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States; Pediatric Blood and Cancer; (2018).

  • Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors; Pediatric Blood and Cancer; (2018).

  • Outcomes following proton therapy for pediatric ependymoma; Acta Oncologica; (2018).

  • Implementing the psychosocial standards in pediatric cancer: Current staffing and services available; Pediatric Blood and Cancer; (2017).

  • Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas; Pediatric Blood and Cancer; (2017).

  • Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma; Advances in Radiation Oncology; (2017).

  • Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies; Cancer Medicine; (2016).

  • Proton Therapy for Pediatric Hodgkin Lymphoma; Pediatric Blood and Cancer; (2016).

  • The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation; Bone Marrow Transplantation; (2016).

  • Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer; Pediatric Blood and Cancer; (2015).

  • Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma; Leukemia and Lymphoma; (2015).

  • Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy; Acta Oncologica; (2014).

  • Involved-node proton therapy in combined modality therapy for hodgkin lymphoma: Results of a phase 2 study; International Journal of Radiation Oncology Biology Physics; (2014).

  • Proactive enteral tube feeding in pediatric patients undergoing chemotherapy; Pediatric Blood and Cancer; (2014).

  • A treatment planning comparison of highly conformal radiation therapy for pediatric low-grade brainstem gliomas; Acta Oncologica; (2013).

  • Treatment of relapsed precursor-b acute lymphoblastic leukemia with intensive chemotherapy: Pog (pediatric oncology group) study 9411 (SIMAL 9); Journal of Pediatric Hematology/Oncology; (2013).

  • Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma; International Journal of Radiation Oncology Biology Physics; (2012).

  • Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children's Oncology Group Study; Biology of Blood and Marrow Transplantation; (2012).

  • Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome; Journal of Pediatric Hematology/Oncology; (2010).

  • TROPICS 1: A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters; Journal of Vascular and Interventional Radiology; (2010).

  • A phase 1 study of combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia; Journal of Pediatric Hematology/Oncology; (2009).

  • The effect of cyproheptadine hydrochloride (Periactin) and megestrol acetate (Megace) on weight in children with cancer/treatment-related cachexia; Journal of Pediatric Hematology/Oncology; (2008).

  • Orbital melanotic neuroectodermal tumor of infancy successfully treated with chemotherapy and subtotal excision; Journal of AAPOS; (2007).

  • Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: A children's oncology group study; Pediatric and Developmental Pathology; (2007).

  • Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice; Journal of Pediatric Hematology/Oncology; (2007).

  • Physician-diagnosed asthma and acute chest syndrome: Associations with NOS polymorphisms; Pediatric Pulmonology; (2007).

  • Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: A Pediatric Oncology Group pilot feasibility study; Journal of Pediatric Hematology/Oncology; (2006).

  • A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: A pediatric blood and marrow transplant consortium study; Bone Marrow Transplantation; (2005).

  • Critical care of the pediatric hematopoietic stem cell recipient in 2005; Pediatric Transplantation; (2005).

  • Gender-specific disease modification by NOS3 (multiple letters); British Journal of Haematology; (2004).

  • Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease; British Journal of Haematology; (2004).

  • Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: A prognostic factor analysis; Journal of Clinical Oncology; (2004).

  • A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters; Journal of Pediatric Hematology/Oncology; (2002).

  • Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome; American Journal of Respiratory and Critical Care Medicine; (2002).

  • Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the intergroup rhabdomyosarcoma study group protocols IRS-II through-IV, 1978-1997; Medical and Pediatric Oncology; (2002).

  • Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium; Pediatric Hematology and Oncology; (2001).

  • Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood; American Journal of Pediatric Hematology/Oncology; (2001).

  • Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the intergroup rhabdomyosarcoma study group; American Journal of Pediatric Hematology/Oncology; (2001).

  • Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group; Medical and Pediatric Oncology; (2001).

  • Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro; Leukemia; (2000).

  • Use of amphotericin B colloidal dispersion in children; American Journal of Pediatric Hematology/Oncology; (2000).

  • Description of a multihospital process to develop a care path for the child with acute lymphoblastic leukemia; Journal of Pediatric Oncology Nursing; (2000).

  • Description of a multihospital process to develop a care path for the child with acute lymphoblastic leukemia.; Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses; (2000).

  • Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer; Cancer; (2000).

  • Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium; Medical and Pediatric Oncology; (2000).

  • Soft-tissue sarcomas of the diaphragm: A report from the intergroup rhabdomyosarcoma study group from 1972 to 1997; American Journal of Pediatric Hematology/Oncology; (2000).

  • Transient monosomy 7: A case series in children and review of the literature; Cancer; (1999).

  • Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease; Blood; (1998).

  • Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia; Clinical Infectious Diseases; (1998).

  • Safety and cost-effectiveness of outpatient total body irradiation in pediatric patients undergoing stem cell transplantation; Journal of Pediatric Hematology/Oncology; (1998).

  • Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: A phase I/II study of the pediatric blood and marrow transplant consortium; Journal of Pediatric Hematology/Oncology; (1998).

  • BK papova virus pneumonia following hematopoietic stem cell transplantation; Bone Marrow Transplantation; (1997).

  • Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia; Cancer; (1997).

  • Disseminated coxsackie A9 infection complicating bone marrow transplantation; Pediatric Infectious Disease Journal; (1996).

  • Nutrition via gastrostomy tube in children with cancer [3]; Journal of Pediatrics; (1996).

  • Acute basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine鈥恗ediated degranulation; Cancer; (1995).

  • Enteral nutritional support by gastrostomy tube in children with cancer; The Journal of Pediatrics; (1995).

  • Amphotericin B colloidal dispersion therapy for invasive mycosis: Report of successful therapy in two pediatric patients; Pediatric Infectious Disease Journal; (1994).

  • Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-1 myeloid cell line; Experimental Hematology; (1993).

  • Midazolam versus fentanyl as premedication for painful procedures in children with cancer; Pediatrics; (1992).

  • Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant; Journal of Pediatric Hematology/Oncology; (1992).

  • Guidelines for hemophilia care; Journal of the Florida Medical Association; (1991).

  • Intravenous midazolam versus fentanyl as premedication for painful procedures in pediatric oncology patients.; Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses; (1991).

  • Reflections On Hemophilia Camp; Clinical Pediatrics; (1991).